Success Metrics

Active Trials
3(75%)

Phase Distribution

Ph phase_1
1
25%
Ph not_applicable
1
25%
Ph phase_3
1
25%
Ph phase_2
1
25%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

4

all time

Status Distribution
Active(3)
Other(1)

Detailed Status

Recruiting3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
3
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 11 (25.0%)
Phase 21 (25.0%)
Phase 31 (25.0%)
N/A1 (25.0%)

Trials by Status

unknown125%
recruiting375%

Recent Activity

3 active trials
Showing 4 of 4
recruitingphase_1

Bicalutamide Therapy in Young Women With NAFLD and PCOS

NCT05979389
recruitingphase_2

Phase II Dutasteride in Combination With CAB vs CAB in SDC

NCT05513365
recruitingphase_3

SRT Versus SRT+ADT in Prostate Cancer

NCT05019846
unknownnot_applicable

The RolE oF Androgen Excess in MUscle Energy MetaboLism in Women With PolyCystic Ovary Syndrome (REFUEL PCOS) Study 2

NCT05647356

Clinical Trials (4)

Showing 4 of 4 trials
NCT05979389Phase 1

Bicalutamide Therapy in Young Women With NAFLD and PCOS

Recruiting
NCT05513365Phase 2

Phase II Dutasteride in Combination With CAB vs CAB in SDC

Recruiting
NCT05019846Phase 3

SRT Versus SRT+ADT in Prostate Cancer

Recruiting
NCT05647356Not Applicable

The RolE oF Androgen Excess in MUscle Energy MetaboLism in Women With PolyCystic Ovary Syndrome (REFUEL PCOS) Study 2

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4